Boryung’s Two-Track R&D Strategy: Innovative Drugs And Cash Cows
Initial Oncology Focus
Executive Summary
Boryung’s chief technology officer outlines R&D strategy to move forward as a Korea-based global pharma firm and how domestic pharmas are juggling new drug development and generating cash cows.